TRUP
TRUPANION, INC.
$21.49
-1.78%
$954.4M
No data for this timeframe.
Vol
Market Cap$954.4M
Cap SizeSmall Cap
Analyst ConsensusBuy (67%)
Inst. Holders8 funds
Inst. Value$259.9M
Inst. Activity1 buys / 1 sells
Insider Activity0B / 6S
Insider Net $-$576.2K
SEC Reports3
Recent Activity
May 11, 2026
Insider
Dodson Paulette R. sold 4,031 shares
Director @ $0.00 ($0.00)
May 11, 2026
Insider
RUBIN HOWARD E sold 562 shares
Director @ $0.00 ($0.00)
May 11, 2026
Insider
Broden Max sold 6,375 shares
Director @ $0.00 ($0.00)
Apr 30, 2026
earnings
Trupanion Reports First Quarter 2026 Results
Trupanion today announced financial results for the first quarter ended March 31, 2026.
Apr 27, 2026
SEC
Trupanion filed additional definitive proxy materials (DEFA14A) providing notice of internet availability of proxy mater
DEFA14A — Impact 2/10
Mar 30, 2026
SEC
John Gallagher, an officer of Trupanion, filed a Form 144 to propose selling 5,283 shares of common stock, valued at app
144 — Impact 2/10
Mar 7, 2026
SEC
Trupanion's Chief Revenue Officer, Emily Dreyer, sold 7,792 shares in an open-market transaction for approximately $219,
CLUSTER — Impact 3/10
Inst.
BANK OF AMERICA CORP — TRIM
597,802 shares ($22.3M)
Price Targets
$39.75
+85.0% upside
Strong Buy
Current $21.49
Low $28.00
Median $39.50
High $52.00
4 analysts
$28.00
$52.00
Analyst Ratings
4Strong Buy
4Buy
4Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 14, 2026 | B of A Securities | MAINTAIN | Buy → Buy |
| Apr 9, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral → Neutral |
| Mar 31, 2026 | Stifel | MAINTAIN | Hold → Hold |
| Feb 13, 2026 | Stifel | MAINTAIN | Hold → Hold |
| Feb 13, 2026 | Piper Sandler | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.94 ▼ -1.1% | $0.94 — $0.94 | 29% YoY | 1 |
| Next Q | $0.98 ▼ -3.9% | $0.98 — $0.98 | 28% YoY | 1 |
| Current FY | $3.92 ▼ -0.8% | $3.92 — $3.92 | 42% YoY | 1 |
| Next FY | $4.31 ▲ +1.4% | $4.31 — $4.31 | 10% YoY | 1 |
Latest Reports
NEUTRAL
DEFA14A
2/10
Trupanion filed additional definitive proxy materials (DEFA14A) providing notice of internet availability of proxy mater
Apr 27, 2026
NEUTRAL
144
2/10
John Gallagher, an officer of Trupanion, filed a Form 144 to propose selling 5,283 shares of common stock, valued at app
Mar 30, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $131.0M | — |
| FMR LLC | $52.3M | ADD |
| MORGAN STANLEY | $29.4M | TRIM |
| BANK OF AMERICA CORP | $22.3M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $12.4M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 11, 2026 | Dodson Paulette | A | $0.00 |
| May 11, 2026 | RUBIN HOWARD | A | $0.00 |
| May 11, 2026 | Broden Max | A | $0.00 |
| May 11, 2026 | POWELL BRADLEY | A | $0.00 |
| May 11, 2026 | MCLAUGHLIN ELIZABETH | A | $0.00 |
8 institutional holders with $259.9M total value (6,955,451 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 3,505,021 | $131.0M | 50.4% | — |
| 2 | FMR LLC | 1,400,657 | $52.3M | 20.1% | ADD +36.8% |
| 3 | MORGAN STANLEY | 787,460 | $29.4M | 11.3% | TRIM -31.3% |
| 4 | BANK OF AMERICA CORP /DE/ | 597,802 | $22.3M | 8.6% | TRIM -39.6% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 330,521 | $12.4M | 4.8% | NEW |
| 6 | TWO SIGMA INVESTMENTS, LP | 205,055 | $7.7M | 2.9% | DOUBLED +3201.0% |
| 7 | WELLS FARGO & COMPANY/MN | 122,935 | $4.6M | 1.8% | DOUBLED +551.6% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 6,000 | $224.2K | 0.1% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | TRIM | 989,796 | 597,802 | -39.6% | $22.3M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 6,000 | — | $224.2K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 6,799 | 224,433 | +3201.0% | $9.7M | 2025-Q3 |
| UBS Group AG | DOUBLED | 62,268 | 176,289 | +183.1% | $7.6M | 2025-Q3 |
| FMR LLC | ADD | 931,799 | 1,274,870 | +36.8% | $70.6M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 15,782 | 102,829 | +551.6% | $5.7M | 2025-Q2 |
| UBS Group AG | TRIM | 148,957 | 62,268 | -58.2% | $3.4M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 119,538 | 6,799 | -94.3% | $376.3K | 2025-Q2 |
| FMR LLC | TRIM | 1,435,534 | 931,799 | -35.1% | $34.7M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 628,241 | 400,369 | -36.3% | $14.9M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 195,451 | 119,538 | -38.8% | $4.5M | 2025-Q1 |
| UBS Group AG | DOUBLED | 32,851 | 147,589 | +349.3% | $7.1M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 10,962 | 15,798 | +44.1% | $761.5K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 1,477,498 | 1,014,453 | -31.3% | $42.6M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 300,414 | — | $12.6M | 2024-Q3 |
14 unique insiders with 6 transactions. Net insider value: -$576.2K ($0.00 bought, $576.2K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 11, 2026 | Dodson Paulette R. | Director | A | 4,031 | $0.00 | $0.00 |
| May 11, 2026 | RUBIN HOWARD E | Director | A | 562 | $0.00 | $0.00 |
| May 11, 2026 | Broden Max | Director | A | 6,375 | $0.00 | $0.00 |
| May 11, 2026 | POWELL BRADLEY S | Director | A | 6,563 | $0.00 | $0.00 |
| May 11, 2026 | MCLAUGHLIN ELIZABETH | Director | A | 3,281 | $0.00 | $0.00 |
| May 6, 2026 | RAWLINGS DARRYL | Director | J | 1,359 | $0.00 | $0.00 |
| Apr 28, 2026 | GALLAGHER JOHN R | Chief Operating Officer | SELL | 431 | $27.47 | $11.8K |
| Mar 30, 2026 | GALLAGHER JOHN R | Chief Operating Officer | SELL | 430 | $25.47 | $11.0K |
| Mar 4, 2026 | DREYER EMILY | Chief Revenue Officer | SELL | 7,792 | $28.15 | $219.3K |
| Feb 27, 2026 | Qureshi Fawwad | Chief Financial Officer | SELL | 2,837 | $26.46 | $75.1K |
| Feb 27, 2026 | GALLAGHER JOHN R | Chief Operating Officer | SELL | 5,283 | $26.52 | $140.1K |
| Feb 25, 2026 | DREYER EMILY | Chief Revenue Officer | M | 1,482 | $0.00 | $0.00 |
| Feb 25, 2026 | WHEELER SIMON | EVP, Trupanion International | M | 322 | $0.00 | $0.00 |
| Feb 25, 2026 | Tooth Margaret | CEO | M | 3,266 | $0.00 | $0.00 |
| Feb 25, 2026 | Tooth Margaret | CEO | M | 3,266 | $0.00 | $0.00 |
| Feb 25, 2026 | MCGIBNEY BRENNA | Chief Administration Officer | M | 233 | $0.00 | $0.00 |
| Feb 25, 2026 | MCGIBNEY BRENNA | Chief Administration Officer | M | 233 | $0.00 | $0.00 |
| Feb 25, 2026 | RAWLINGS DARRYL | Director | M | 946 | $0.00 | $0.00 |
| Feb 25, 2026 | WHEELER SIMON | EVP, Trupanion International | M | 322 | $0.00 | $0.00 |
| Feb 25, 2026 | BEARMAN ASHER | Chief Legal Officer | M | 180 | $0.00 | $0.00 |
| Feb 25, 2026 | DREYER EMILY | Chief Revenue Officer | M | 1,482 | $0.00 | $0.00 |
| Feb 25, 2026 | WEINRAUCH STEVE | EVP, North Am & Vet Strategy | M | 531 | $0.00 | $0.00 |
| Feb 25, 2026 | RAWLINGS DARRYL | Director | M | 946 | $0.00 | $0.00 |
| Feb 25, 2026 | Qureshi Fawwad | Chief Financial Officer | SELL | 4,645 | $25.61 | $119.0K |
| Feb 25, 2026 | Qureshi Fawwad | Chief Financial Officer | M | 3,750 | $0.00 | $0.00 |
| Feb 25, 2026 | BEARMAN ASHER | Chief Legal Officer | M | 180 | $0.00 | $0.00 |
| Feb 25, 2026 | GALLAGHER JOHN R | Chief Operating Officer | M | 735 | $0.00 | $0.00 |
| Feb 25, 2026 | GALLAGHER JOHN R | Chief Operating Officer | M | 735 | $0.00 | $0.00 |
| Feb 25, 2026 | WEINRAUCH STEVE | EVP, North Am & Vet Strategy | M | 531 | $0.00 | $0.00 |
| Feb 22, 2026 | BEARMAN ASHER | Chief Legal Officer | M | 973 | $0.00 | $0.00 |
| Feb 22, 2026 | RUBIN HOWARD E | Director | M | 106 | $0.00 | $0.00 |
| Feb 22, 2026 | Tooth Margaret | CEO | M | 6,250 | $0.00 | $0.00 |
| Feb 22, 2026 | MCGIBNEY BRENNA | Chief Administration Officer | M | 1,250 | $0.00 | $0.00 |
| Feb 22, 2026 | Qureshi Fawwad | Chief Financial Officer | M | 913 | $0.00 | $0.00 |
| Feb 22, 2026 | BEARMAN ASHER | Chief Legal Officer | M | 973 | $0.00 | $0.00 |
| Feb 22, 2026 | DREYER EMILY | Chief Revenue Officer | M | 2,249 | $0.00 | $0.00 |
| Feb 22, 2026 | POWELL BRADLEY S | Director | M | 638 | $0.00 | $0.00 |
| Feb 22, 2026 | WHEELER SIMON | EVP, Trupanion International | M | 938 | $0.00 | $0.00 |
| Feb 22, 2026 | RUBIN HOWARD E | Director | M | 106 | $0.00 | $0.00 |
| Feb 22, 2026 | RAWLINGS DARRYL | Director | M | 313 | $0.00 | $0.00 |
| Feb 22, 2026 | RAWLINGS DARRYL | Director | M | 313 | $0.00 | $0.00 |
| Feb 22, 2026 | MCGIBNEY BRENNA | Chief Administration Officer | M | 1,250 | $0.00 | $0.00 |
| Feb 22, 2026 | WEINRAUCH STEVE | EVP, North Am & Vet Strategy | M | 2,932 | $0.00 | $0.00 |
| Feb 22, 2026 | WEINRAUCH STEVE | EVP, North Am & Vet Strategy | M | 2,932 | $0.00 | $0.00 |
| Feb 22, 2026 | Qureshi Fawwad | Chief Financial Officer | M | 913 | $0.00 | $0.00 |
| Feb 22, 2026 | DREYER EMILY | Chief Revenue Officer | M | 2,249 | $0.00 | $0.00 |
| Feb 22, 2026 | POWELL BRADLEY S | Director | M | 638 | $0.00 | $0.00 |
| Feb 22, 2026 | WHEELER SIMON | EVP, Trupanion International | M | 938 | $0.00 | $0.00 |
| Feb 22, 2026 | Tooth Margaret | CEO | M | 6,250 | $0.00 | $0.00 |
| Feb 22, 2026 | GALLAGHER JOHN R | Chief Operating Officer | M | 2,570 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 2.3/10.
NEUTRAL
DEFA14A
2/10
Trupanion filed additional definitive proxy materials (DEFA14A) providing notice of internet availab
Apr 27, 2026
NEUTRAL
144
2/10
John Gallagher, an officer of Trupanion, filed a Form 144 to propose selling 5,283 shares of common
Mar 30, 2026
NEUTRAL
CLUSTER
3/10
Trupanion's Chief Revenue Officer, Emily Dreyer, sold 7,792 shares in an open-market transaction for
Mar 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 12 analysts: 4 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$39.75 mean target
+85.0% upside
Strong Buy (2.17)
$28.00 Low
$52.00 High
| Metric | Value |
|---|---|
| Current Price | $21.49 |
| Target Low | $28.00 |
| Target Mean | $39.75 |
| Target Median | $39.50 |
| Target High | $52.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (2.17) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.94 | $0.94 | $0.94 | 29.4% | -1.1% | 0↑ 1↓ | $0.4B | 10.2% | 1 |
| Next Q 2026-09-30 |
$0.98 | $0.98 | $0.98 | 27.8% | -3.9% | 0↑ 1↓ | $0.4B | 8.5% | 1 |
| Current FY 2026-12-31 |
$3.92 | $3.92 | $3.92 | 42.3% | -0.8% | 0↑ 1↓ | $1.6B | 9.7% | 1 |
| Next FY 2027-12-31 |
$4.31 | $4.31 | $4.31 | 10.0% | +1.4% | 1↑ 0↓ | $1.7B | 8.6% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.940 | |
| 7d ago | $0.950 | -0.010 |
| 30d ago | $0.950 | -0.010 |
| 60d ago | $0.940 | |
| 90d ago | $0.940 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 14, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| Apr 9, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral | Neutral |
| Mar 31, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Feb 13, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Feb 13, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Jan 29, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Jan 14, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral | Neutral |
| Dec 19, 2025 | Piper Sandler | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 4 | 4 | 4 | 0 | 0 | 67% | |
| Apr 1, 2026 | 4 | 4 | 4 | 0 | 0 | 67% | |
| Mar 1, 2026 | 4 | 4 | 4 | 0 | 0 | 67% | |
| Feb 1, 2026 | 4 | 4 | 4 | 0 | 0 | 67% | |
| Jan 1, 2026 | 4 | 4 | 4 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 30, 2026
earnings
Trupanion Reports First Quarter 2026 Results
Trupanion today announced financial results for the first quarter ended March 31, 2026.
Apr 30, 2026
earnings_calendar
TRUP Q1 2026 Earnings After Market Close — 2026-04-30
Apr 27, 2026
other
Trupanion Publishes 2025 Annual Letter to Shareholders
<p>SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 20
Apr 16, 2026
earnings
Trupanion Announces First Quarter 2026 Earnings Release and Conference Call
<p>SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it w
Apr 16, 2026
other
Trupanion Launches 2026 Veterinary Appreciation Day® Awards with New Team Excellence Category
<p align="center"><em>Trupanion calls for nominations to honor the “everyday heroes”—from veterinarians to support staff—providing exceptional care fo